CL9-17380-06221
2 vaccinations
5 coded responses
23 check-ins
5 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 402 / KY
- Registered
- 2021-02-25
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-25
Registered in v-safe
-
2021-02-25
Dose 1 — Pfizer-BioNTech
- 2021-02-25
-
2021-02-26
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-02-27
- 2021-02-28
- 2021-03-01
- 2021-03-02
- 2021-03-03
- 2021-03-04
- 2021-03-11
-
2021-03-18
Dose 2 — Pfizer-BioNTech
- 2021-03-18
-
2021-03-19
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-20
Survey response — days 1–6 daily, dose 2MedDRA: Visual impairment — Feeling: Fair · Headache, Muscle or body aches · Be unable to do your normal daily activitiesFree text: Since getting the shot, I've had a problem with my left eye. There's a "blot" in the vision of my left eye. Similar to an afterimage after looking at a bright light; but this doesn't seem to go away.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-21
Survey response — days 1–6 daily, dose 2MedDRA: Eye disorder — Feeling: GoodFree text: Left eye still has the problem explained yesterday.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-22
Survey response — days 1–6 daily, dose 2MedDRA: Metamorphopsia — Feeling: Good · Headache · Be unable to do your normal daily activitiesFree text: On-going problem with left eye field of vision blank spotMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-24
Survey response — days 1–6 daily, dose 2MedDRA: Unevaluable event — Feeling: Good · Be unable to do your normal daily activitiesFree text: left eye vision has improvedthe blank spot is still there, but less opaque today. Still a discouragement to reading.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-25
Survey response — day 7, dose 2MedDRA: Unevaluable event — Feeling: GoodFree text: Left eye improvingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-01
- 2021-04-08
- 2021-04-17
- 2021-04-22
- 2021-04-29
- 2021-09-16
- 2022-03-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-25 | Pfizer-BioNTech | |
| 2 | 2021-03-18 | Pfizer-BioNTech |
Free text
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): Since getting the shot, I've had a problem with my left eye. There's a "blot" in the vision of my left eye. Similar to an afterimage after looking at a bright light; but this doesn't seem to go away.
Systemic reaction (other): Left eye still has the problem explained yesterday.
Systemic reaction (other): On-going problem with left eye field of vision blank spot
Systemic reaction (other): left eye vision has improvedthe blank spot is still there, but less opaque today. Still a discouragement to reading.
Release 6 — day 7, dose 2
Systemic reaction (other): Left eye improving
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Eye disorder | ✓ | ✓ | ✓ |
| SRO | Metamorphopsia | ✓ | ✓ | ✓ |
| SRO | Unevaluable event | ✓ | ✓ | ✓ |
| SRO | Visual impairment | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release